$65.08
-0.55-0.84%
Últ. Act.: Oct 1, 4:00 PM
$65.08
-0.55-0.84%
National Health Investors (NHI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
National Health Investors (NHI) emitió su última guía sobre agosto 10, 2026 para fiscal year 2026. La compañía estimó unas ganancias por acción en el rango de $4.74 - $4.79, en comparación con una estimación de consenso de EPS de $4.87.
En comparación con la previsión anterior, National Health Investors mantenido redujo su previsión de BPA desde un rango anterior de $4.74 - $4.79.
National Health Investors ha emitido 16 actualizaciones de orientación entre el noviembre 8, 2022 y el agosto 10, 2026. During this period, the company raised its outlook 9 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.26 | $1.21 | $0.97 | $0.86 |
| Actual | $1.19 | $1.23 | $1.22 | $1.32 |
| Surprise | -5.56% | +1.65% | +25.8% | +53.5% |
| Revenue | ||||
| Estimate | $113.6M | $106.0M | $96.6M | $83.7M |
| Actual | $121.3M | $115.1M | $105.8M | $71.0M |
| Surprise | +6.79% | +8.64% | +9.54% | -15.2% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.16 | $1.15 | $1.21 | $1.26 |
| Revenue | ||||
| Consensus | $110.4M | $112.9M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $1.19 | $1.26 | -5.56 % |
| Q1 | May 4, 2026 | $1.23 | $1.21 | 1.65 % |
| Q4 | Feb 26, 2026 | $1.22 | $0.97 | 25.8 % |
| Q3 | Nov 6, 2025 | $1.32 | $0.86 | 53.5 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $121.32M | $113.61M | 6.79 % |
| Q1 | May 4, 2026 | $115.13M | $105.97M | 8.64 % |
| Q4 | Feb 26, 2026 | $105.82M | $96.60M | 9.54 % |
| Q3 | Nov 6, 2025 | $70.98M | $83.72M | -15.2 % |